Patient Intake At the 'MOvement and REhabilitation (MO.RE.)

NCT ID: NCT06858241

Last Updated: 2025-03-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

95 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-08-01

Study Completion Date

2024-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In recent years, there has been an exponential increase in studies regarding the benefits of physical activity in oncology, with significant results on improving both physical and psychological outcomes. When appropriately dosed, physical activity can help individuals with a history of cancer to cope with pain and Cancer-Related Fatigue, and improve their quality of life, both during and after cancer treatments.

Given the incidence and prevalence of cancer, along with the increase in survival due to advancements in cancer care, it is becoming increasingly important to promote an active lifestyle.

For this reason, in August 2022, the MOvement and REhabilitation (MO.RE.) clinic was opened by the S.C. of MFR, dedicated to individuals with a history of cancer at any stage of treatment, with the aim of offering consultations with an experienced physiotherapist to personalize a physical activity program that can help regain a good quality of life, return to daily activities, and prevent the onset of other diseases and recurrences.

The clinic also provides therapeutic education activities, following WHO guidelines, on proper lifestyle for wellness and secondary prevention.

The aim of our study is to retrospectively analyze the patients who requested a consultation at the MO.RE. clinic between August 2022 and June 2024, in order to describe and evaluate the appropriateness of access to the clinic, the expressed needs, and some clinical and rehabilitative data."

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Oncologic Complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients who requested a consultation at the MO.RE. clinic between August 2022 and June 2024

Patients with a history of malignant tumor diagnosis, managed by the Oncology and Hematology Units that need a MO.RE. clinic consultation

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of malignant tumor
* Access to the MO.RE. clinic for recommendations on exercise/physical activity
* Age over 18 years

Exclusion Criteria

* Language barrier
* Conditions that prevent the individual from performing physical activity independently
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Azienda USL Reggio Emilia - IRCCS

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stefania Fugazzaro, MD

Role: PRINCIPAL_INVESTIGATOR

AUSL-IRCCS of Reggio Emilia

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

AUSL-IRCCS of Reggio EmiliaOperational Unit of Physical Medicine and Rehabilitation AUSL - IRCCS Reggio Emilia, Reggio Emilia, Emilia Romagna 42123

Reggio Emilia, , Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

299/2024/OSS/AUSLRE

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Movement and Health Beyond Care (MoviS)
NCT04818359 ACTIVE_NOT_RECRUITING NA